General Information of DME (ID: DEOXTPZ)

DME Name Methylenetetrahydrofolate reductase (MTHFR) DME Info
Gene Name MTHFR

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
5 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benazepril DMH1M9B Hypertension BA00-BA04 Approved [1]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [2]
Folic Acid DMEMBJC Colorectal carcinoma Approved [3]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [4]
Methotrexate DM2TEOL Anterior urethra cancer Approved [5]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISO-901 DMBQ8CA N. A. N. A. Phase 1 [6]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Effects of MTHFR and MS gene polymorphisms on baseline blood pressure and Benazepril effectiveness in Chinese hypertensive patients. J Hum Hypertens. 2011 Mar;25(3):172-7.
2 5-Fluorouracil pharmacogenomics: still rocking after all these years? Pharmacogenomics. 2011 Feb;12(2):251-65.
3 Genetic variation: impact on folate (and choline) bioefficacy. Int J Vitam Nutr Res. 2010 Oct;80(4-5):319-29.
4 Purification and properties of 5,10-methylenetetrahydrofolate reductase, an iron-sulfur flavoprotein from Clostridium formicoaceticum. J Biol Chem. 1984 Sep 10;259(17):10845-9.
5 The pharmacogenetics of methotrexate. Rheumatology (Oxford). 2007 Oct;46(10):1520-4.
6 Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy? Cancer Chemother Pharmacol. 2006 Jun;57(6):835-40.